DRUG-THERAPY

被引:105
作者
ROCHON, PA
GURWITZ, JH
机构
[1] UNIV TORONTO,MT SINAI HOSP,DEPT MED,DIV GERIATR MED,TORONTO,ON,CANADA
[2] UNIV TORONTO,MT SINAI HOSP,DEPT PREVENT MED & BIOSTAT,TORONTO,ON,CANADA
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV GERONTOL,PROGRAM ANAL CLIN STRATEGIES,BOSTON,MA
[4] BROCKTON W ROXBURY VET AFFAIRS MED CTR,BOSTON,MA
来源
LANCET | 1995年 / 346卷 / 8966期
关键词
D O I
10.1016/S0140-6736(95)92656-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug therapy for individuals of any age is difficult but prescribing for older patients offers special challenges. Older people take about three times as many prescription medications as younger individuals do, mainly because of their increased prevalence of chronic medical conditions.(1) However, taking several drugs together substantially increases the risk of drug interactions, unwanted effects, and adverse reactions. Many medications need to be used with special caution because of age-related changes in pharmacokinetics and pharmacodynamics.(2) For some drugs, an increase in the volume of distribution (eg, diazepam) or a reduction in drug clearance (eg, digoxin) may lead to higher plasma concentrations in older than in younger patients.(2) Pharmacodynamic changes with ageing may result in an increased sensitivity to the effects of certain drugs (eg, opioids) for any given plasma concentration.(3) While a physician can usually do little to alter the characteristics of individual older patients to affect the kinetics or dynamics of drugs, the decision whether to prescribe anything at all, the choice of drug, and the manner in which it is to be used (eg, dose and duration of therapy) are all factors that are under control of the prescriber. Patient adherence to the regimen prescribed is important, and there should be a partnership between physician and patient in therapeutic decision making. We will discuss here mays of improving prescribing for older patients. Specifically, we will examine the scarcity of information to guide prescribing decisions, the general principles of prudent prescribing, and the opportunities to clarify and expand knowledge about drug therapy in the elderly.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 38 条
[1]  
Chrischilles, Foley, Wallace, Et al., Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly, J Gerontol, 47, pp. M137-144, (1992)
[2]  
Greenblatt, Sellers, Shader, Drug disposition in old age, N Engl J Med, 306, pp. 1081-1088, (1982)
[3]  
Scott, Stanski, Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation, J Pharmacol Exp Ther, 240, pp. 159-166, (1987)
[4]  
Gurwitz, Col, Avorn, The exclusion of the elderly and women from clinical trials in acute myocardial infarction, JAMA, 268, pp. 1417-1422, (1992)
[5]  
Rochon, Fortin, Dear, Minaker, Chalmers, Reporting of age data in clinical trials of arthritis: deficiencies and solutions, Arch Intern Med, 153, pp. 243-248, (1993)
[6]  
Trimble, Carter, Cain, Freidlin, Ungerleider, Friedman, Representation of older patients in cancer treatment trials, Cancer, 74, pp. 2208-2214, (1994)
[7]  
Atrial Fibrillation Investigators, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised controlled trials, Archives of Internal Medicine, 154, pp. 1449-1457, (1994)
[8]  
Stroke Prevention in Atrial Fibrillation Investigators, Stroke prevention in atrial fibrillation study: final results, Circulation, 84, pp. 527-539, (1991)
[9]  
Beers, Ouslander, Rollingher, Reuben, Brooks, Beck, Explicit criteria for determining inappropriate medication use in nursing home residents, Arch Intern Med, 151, pp. 1825-1832, (1991)
[10]  
Willcox, Himmelstein, Woolhandler, Inappropriate drug prescribing for the community-dwelling elderly, JAMA, 272, pp. 292-296, (1994)